ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-H.R. 485 Protecting Health Care for All Patients Act of 2023 -FDA on status of safe and effective decongestants -HHS on health disparity populations -Food and Drug Administration's Patient-Focused Drug Development Series
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER New | — |
| MICHAEL WARD | — |
Medicare/Medicaid MMM
-Implementation of Medicare Part D beneficiary affordability provisions -Use of Explanation of Benefits to educate and inform beneficiaries -Proposed National Coverage Determination (NCD) for Pre-Exposure Prophylaxis for Human Immunodeficiency Virus Infection Prevention -Proposed NCD for Aꞵ Positron Emission Tomography scans -Proposed guidance on National Coverage Analysis process -Proposed guidance on Coverage with Evidence Development -Proposed guidance on Transitional Coverage for Emerging Technologies pathway -CY 2024 OPPS/PFS Final Rule -Stakeholder input in the Medicare drug price negotiation process -AP quality measure on antipsychotics for long-term stay in secure nursing facilities
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Budget/Appropriations BUD
-FY24 report language for the Food and Drug Administration -FY24 appropriations for the United States Preventative Services Task Force
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADINA ROSE LASSER | — |
| MICHAEL WARD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.